Approval · Notice of Compliance 23917 · 2020
TOMVI: Notice of Compliance 23917
Issued July 16, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23917
- Date
- July 16, 2020
- Company
- Sterimax Inc.Oakville, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TOMVI | 02498650 | Marketed |
Medicinal ingredients
- ETOMIDATE 2 MG per ML